For its third fiscal quarter (ending September 30), Bausch Health Cos Inc (NYSE: BHC) has reported a -195% decline in E.P.S. from $1.10 a year ago to $-1.04 in the current quarter. This performance was $-1.96 short of the consensus estimate of $0.92. E.P.S. were $-2.65 for the latest four quarters through September 30 versus $0.70 for the same period a year ago — a decline of -479%.
Recent Price Action
On 11/2/23, Bausch Health Cos Inc (NYSE: BHC) stock enjoyed a large increase of 3.7%, closing at $7.34. Relative to the market the stock has been strong over the last nine months and has risen 6.2% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, BHC is expected to be an important Value Eraser.
Bausch Health is currently unrated.
Rating Review
The stock is currently unrated.